I also think there's something interesting going forward to look at how we might measure the effectiveness of this bill as it moves through here tonight. It'd be interesting to have some sort of a snapshot before and after. What impact did the passage of this bill have on sun-induced skin cancers? Hard to determine, but, you know, if there was a 10 percent reduction in skin cancers for no other obvious cause, one might reliably point to, well, maybe it was the passage of good legislation. So it'd be good to snapshot before this bill is actually enabled. And that sort of leads to something which one of the other members has spoken about, and that is the ability to monitor compliance for what we're looking to achieve here today. That manufacturers and retailers will adhere to the standards that we're wanting to embody here, and how do we monitor that? Who monitors that? That's all been part of the committee discussion, certainly under the Fair Trading Act. But it will be interesting to look and see how resources are applied, how often, how much, and what those findings are, because that is a large part of what we're looking to do here tonight.